Alogliptin Synthesis via One-Pot Halogenation

The patent combines multiple separate synthesis steps into a single one-pot reaction. The process integrates the formation of the pyrimidine ring, introduction of the nitrile group, and installation of the piperidine moiety into one continuous reaction sequence, eliminating the need for intermediate isolation and reducing the total number of steps from multiple sequential reactions to a single consolidated process.

The patent extracts and eliminates hazardous reagents (sodium hydride, lithium bromide) and unnecessary intermediate steps from the existing multi-step synthesis process. By removing these dangerous components and simplifying the reaction sequence, the invention achieves the same synthetic outcome through a safer, more streamlined pathway that avoids problematic reagents entirely.

The patent employs readily available, non-hazardous reagents that can be easily handled and disposed of safely. Instead of using expensive and dangerous reagents like sodium hydride, the invention utilizes common, benign chemicals that maintain reaction efficiency while eliminating safety concerns associated with hazardous material handling, storage, and disposal.

The patent transforms the synthesis approach to avoid harmful reagents entirely, converting a potentially dangerous process into a safe one. By redesigning the reaction pathway to use inherently safer reagents that still achieve the desired chemical transformations, the invention turns the challenge of avoiding hazardous materials into an opportunity to create a more sustainable and safer manufacturing process.